Skip to main content
. 2020 Sep 22;12(9):2721. doi: 10.3390/cancers12092721

Figure 1.

Figure 1

Flow cytometry data on 5T33 MM (multiple myeloma) cells showing the specific binding of unmodified 9E7.4 and modified 9E7.4 SAB (N-succinimidyl-3-[211At]astatobenzoate prosthetic group). Antibodies were incubated for 1 h and revealed with an anti-rat secondary antibody labeled with phycoerythrin.